BioNTech Leans Into Platform Expansion with BMS Partnership and CureVac Buyout
July 2025 saw BioNTech execute two landmark transactions, positioning it as a leader in next-generation oncology.In June, the company entered […]
July 2025 saw BioNTech execute two landmark transactions, positioning it as a leader in next-generation oncology.In June, the company entered […]